25 results
Thumbnail

D1.452 - Remission as a therapeutic goal in chronic rhinosinusitis with nasal polyps treated with Dupilumab: a multicenter real-world study

Thumbnail

D1.453 - Pregnancy in Eosinophilic Granulomatosis with Polyangiitis (EGPA): a case report and literature review

Thumbnail

D1.455 - Dupilumab Efficacy in Unified Airways Disease: Pooled Analysis of Patients With Chronic Rhinosinusitis With Nasal Polyps/Allergic Fungal Rhinosinusitis With Coexisting Asthma in Ph3/4 Clinical Trials

Thumbnail

D1.457 - Clinical and immune profile of newborns born to mothers with inflammatory diseases exposed to biological drugs during pregnancy

Thumbnail

D1.460 - Diagnostic Opportunities in Type 2 Inflammations - A Machine-Learning Approach: EAACI Task Force Update

Thumbnail

D1.461 - Dupilumab as a Steroid-Sparing Treatment Option for Pemphigus Vulgaris: A Case Series from a Tertiary Centre

Thumbnail

D1.463 - Real-World Transition from Reference Omalizumab to Biosimilar Omlyclo in Patients with Chronic Urticaria: A Single-Center Descriptive Study

Thumbnail

D1.451 - Adherence and persistence to biological treatments in patients with CRSwNP and comorbid asthma

Thumbnail

D1.456 - Integrated Analysis of Nemolizumab Immunogenicity Indicates No Effect on the Overall Benefit-Risk Profile of Nemolizumab in Patients with Atopic Dermatitis or with Prurigo Nodularis

Thumbnail

D1.496 - Variation in platelet-activating factor levels among patients with chronic spontaneous urticaria

Thumbnail

D1.507 - Biomarkers of T2-airway inflammation in patients with asthma and COPD overlap

Thumbnail

D1.495 - Noninvasive Monitoring of Cutaneous Molecular Changes During Improvement of Infantile Atopic Dermatitis: Application of Skin Surface Lipid RNA (SSL-RNA) Analysis

Thumbnail

D1.497 - An integrated multiomic insight to nonsteroidal anti-inflammatory drug-induced acute urticaria/angioedema

Thumbnail

D1.498 - Altered B Cell Dynamics in Childhood-Onset Systemic Lupus Erythematosus: Insights from Disease States and Rituximab Treatment

Thumbnail

D1.499 - A clinically validated kinin biomarker assay to differentiate bradykinin-mediated from mast cell-mediated angioedema

Thumbnail

D1.503 - Immunoglobulin Abnormalities in Cronkhite-Canada Syndrome: A Focus on IgE and IgG4

Thumbnail

D1.504 - Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2: Clinical Characteristics and Outcomes in a series of pediatric cases

Thumbnail

D1.505 - Impact of patient factors on the stability of anti-IgE treatment response in chronic spontaneous urticaria

Thumbnail

D1.506 - Mast cell activation and type 2 inflammation in heart failure with preserved ejection fraction: a pilot cross-sectional study

Thumbnail

D1.508 - Assessment of automated serum sIgG testing for key bacterial pathogens in Cystic Fibrosis